News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MedCap Corp. (MPCPF.PK) Receives Experimental Status On Test Kit



10/19/2005 5:13:10 PM

TORONTO, March 31 /PRNewswire-FirstCall/ -- MedCap Corp (Pinksheets: MPCPF) is pleased to announce that its AccuScan Heroin/Morphine test kit has been given experimental status for testing purposes and is being used in several hospitals in the Beijing area as well as being used by law enforcement agencies for testing individuals who are known to use illegal substances. Authorities have been pleased with the performance to date.

This kit has been submitted for regulatory approval in China. Based on meetings with representatives of the regulatory bodies, it is anticipated that this kit will receive approval in approximately 60 days. As a result of the interest in all of the AccuScan kits by the regulatory agencies, the Company will begin the approval process in China for the other AccuScan test kits.

MedCap Corp trades in the United States on the Pinksheets under the symbol "MPCPF".

For further information, please contact Cazgeld Capital Corporation at (416) 363 0070 or at http://www.medccorp.com/.

This release may contain forward-looking statements that involve uncertainties and risks. Actual results may differ materially from any results predicted. MedCap undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events of circumstances after the date hereof.

MedCap Corp

CONTACT: Cazgeld Capital Corporation at (416) 363 0070


Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES